Phase I and pharmacodynamic study of Triapine®, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia-Reference-Cited by-同舟云学术

Phase I and pharmacodynamic study of Triapine®, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia

Published:2003-12 Issue:12 Volume:27 Page:1077-1083
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Giles Francis J.,Fracasso Paula M.,Kantarjian Hagop M.,Cortes Jorge E.,Brown Randy A.,Verstovsek Srdan,Alvarado Yesid,Thomas Deborah A.,Faderl Stefan,Garcia-Manero Guillermo,Wright Lisa P.,Samson Tom,Cahill Ann,Lambert Paula,Plunkett William,Sznol Mario,DiPersio John F.,Gandhi Varsha

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference26 articles.

1. Giles FJ, Keating A, Goldstone AH, et al. Acute myeloid leukemia. Hematology (Am Soc Hematol Educ Program) 2002;1:73–110.

2. Ribonucleotide reductase—a radical enzyme;Reichard;Science,1983

3. From RNA to DNA, why so many ribonucleotide reductases?;Reichard;Science,1993

4. The evolving role of ribonucleoside reductase inhibitors in hematologic malignancies;Tsimberidou;Expert Rev. Anticancer Ther.,2002

5. Detection of a new substrate-derived radical during inactivation of ribonucleotide reductase from Escherichia coli by gemcitabine 5′-diphosphate;van der Donk;Biochemistry,1998

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of several African swine fever virus replication inhibitors by screening of a library of FDA-approved drugs;Virology;2024-05

2. Human serum albumin as a copper source for anticancer thiosemicarbazones;Metallomics;2023-07-28

3. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present;Biomolecules;2022-06-10

4. Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma;Gene;2022-01

5. The Role of Iron in Cancer Progression;Frontiers in Oncology;2021-11-10